Pragya Gupta, MD
Interventional Pain Medicine · Escondido, CANPI 1740243609
Payments from drug & device makers
Across 168 payments — averaging $3850.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seikagaku Corporation$433K
- AbbVie$71K
- Pfizer$36K
- GRT US Holding, Inc.$31K
- Medtronic$24K
- Eli Lilly$20K
- plus $32K from 18 others
Across 26 payments — averaging $14,758 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Orexo US, Inc.$361K
- MDD US Operations, LLC$19K
- Eli Lilly$3K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seikagaku Corporation | 57 | $433,158 |
| AbbVie | 28 | $71,117 |
| Pfizer | 4 | $35,843 |
| GRT US Holding, Inc. | 5 | $31,172 |
| Medtronic(2 entities) | 16 | $23,517 |
| Eli Lilly | 3 | $20,261 |
| SPR Therapeutics, Inc | 6 | $17,127 |
| Sage Therapeutics, LLC | 3 | $11,462 |
| MDD US Operations, LLC | 15 | $1,255 |
| Regeneron | 1 | $1,023 |
| Lilly USA, LLC | 2 | $385 |
| Collegium Pharmaceutical, Inc. | 16 | $277 |
| Novartis | 1 | $49 |
| Boston Scientific | 1 | $46 |
| Saluda Medical Americas, Inc. | 1 | $30 |
| Fidia Pharma USA Inc. | 1 | $22 |
| Si-bone, Inc. | 1 | $21 |
| Amgen | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Abbott | 1 | $19 |
| Virtus Pharmaceuticals LLC | 1 | $18 |
| Nevro Corp. | 1 | $15 |
| GSK | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
How this compares
$646,885 in reported general payments places this provider in the 95th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Escondido
- Sheldon JordanSanta Monica$3.1M
- Ezekiel FinkBeverly Hills$2.3M
- Matthew DotyOroville$1.3M
- Tim LeierRancho Mirage$749K
- Michael Verdolinla Mesa$563K
- Standiford HelmOrange$476K
- Patrick BuchananCamarillo$453K
- Roy BrownlowSan Diego$452K
- Andrew GermanovichRancho Mirage$408K
- Jonathan GrossmanVisalia$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.